BAAR, CH / / January 19, 2026 / PolyPeptide Group AG (SIX:PPGN), a specialized global CDMO for peptide-based active pharmaceutical ingredients, today announced the successful closing of its ...

Investing.com -- PolyPeptide Group AG on Monday reported revenue of €389 million for the financial year 2025, representing a growth rate of 15.6% compared to the previous year.

ZURICH/FRANKFURT, Nov 11 (Reuters) - Family-owned contract manufacturer PolyPeptide is advancing preparations for a 2021 Zurich stock market listing or potential sale, two people close to the matter ...

There is new research into a new battery technology platform that is completely metal-free. This new battery technology platform utilizes a polypeptide organic radical construction. Almost all Li-ion ...

This collaboration offers an integrated solution for customers seeking to outsource the development and manufacturing of microbial and mammalian-expressed peptide drugs, with scalable options that ...

Growth-oriented private equity firm Arcline Investment Management has acquired Polypeptide Therapeutic Solutions, providing an exit for Columbus Venture Partners. PTS is a GMP-grade manufacturer of ...

Recent advances in synthetic polypeptide and polymer chemistry have transformed the landscape of biomaterials by combining the precision of organic synthesis with the versatile functionalities of ...

VALENCIA, Spain & BOSTON--(BUSINESS WIRE)--Polypeptide Therapeutic Solutions (PTS), a leader in the design, development and custom manufacturing of polyamino-acid based delivery systems for ...